Skip to content
MedsAcross

Brand family

Beqalzi

Sonrotoclax · BeOne Medicines
United States
Presentations
5
Markets
1

Beqalzi is a brand of Sonrotoclax marketed by BeOne Medicines, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Sonrotoclax
Brand owner
BeOne Medicines
Registered in
United States
Strengths and forms
kit, 1 mg tablet, 20 mg tablet, 5 mg tablet, 80 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Beqalzi kitBeOne MedicinesUS FDAAvailable on request
Beqalzi 1 mg tabletOralBeOne MedicinesUS FDAAvailable on request
Beqalzi 20 mg tabletOralBeOne MedicinesUS FDAAvailable on request
Beqalzi 5 mg tabletOralBeOne MedicinesUS FDAAvailable on request
Beqalzi 80 mg tabletOralBeOne MedicinesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Beqalzi

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.